Status:
COMPLETED
Molecular Analysis of Retinoblastoma
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Retinoblastoma
Eligibility:
All Genders
Brief Summary
Retinoblastoma is a childhood tumor of the retina that affects approximately 1 in 18,000 children. Retinoblastoma is more prevalent in Central America, where most patients present with advanced intrao...
Detailed Description
This is a biology protocol with no treatment regimen associated. Following routine enucleation of the retinoblastoma affected eye, a portion of the tumor will be removed and flash frozen and sent to S...
Eligibility Criteria
Inclusion
- Must have clinical diagnosis of retinoblastoma (to be confirmed histologically after enucleation)
- Legal guardians must willing to sign an informed consent indicating that they are aware of this study and its possible benefits. Legal guardians will be given a copy of the consent form.
- Patient is being seen at this AHOPCA institution:
Exclusion
- Ophthalmologist or oncologist is concerned that sampling will interfere with staging.
- Diagnosis other than retinoblastoma.
- Affiliated hospital is unable to provide pathologic evidence of retinoblastoma.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00718783
Start Date
April 1 2007
End Date
December 1 2016
Last Update
December 14 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Calvo Mackenna
Santiago, Santiago Metropolitan, Chile
2
Hospital Escuela Bloque Materno Infantil
Tegucigalpa, Honduras